MAYNE PHARMA GROUP LIMITED — Capital/Financing Update 2014

Feb 18, 2014

19 February 2014

The Manager Company Notices Section ASX Limited Level 45, South Tower, Rialto Towers 525 Collins Street MELBOURNE VIC 3000

Via E-Lodgement

Dear Sir/Madam

Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)

This notice is given by Mayne Pharma Group Limited ACN 115 832 963 (Mayne Pharma) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act).

Mayne Pharma has today issued 22,641,509 fully paid ordinary shares in Mayne Pharma (Placement Shares) to certain institutional and sophisticated investors in accordance with the announcement by Mayne Pharma on 12 February 2014.

Mayne Pharma advises that:

• (a) the Placement Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act;

• (b) this notice is being given under section 708A(5)(e) of the Corporations Act;

• (c) as at the date of this notice, Mayne Pharma has complied with:

  • (i) the provisions of Chapter 2M of the Corporations Act as they apply to Mayne Pharma; and

  • (ii) section 674 of the Corporations Act; and

• (d) as at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) and 708A(8) of the Corporations Act.

Yours sincerely

==> picture [152 x 34] intentionally omitted <==

Mark Cansdale

Group CFO and Company Secretary

==> picture [581 x 69] intentionally omitted <==